Patent directory Β· USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 12187679
Hydroxylated psilocybin derivatives and methods of using
granted -
US 12187992
Method and device for early cancer screening
granted -
US 12188058
Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof
granted -
US 12187804
Multivalent and multispecific 41BB-binding proteins
granted -
US 2025002606
Combination Therapy for Treating Cancer with an Antibody and Intravenous Administration of a Recombinant MVA
granted -
US 12178811
Methods of treating depressive disorders
granted -
US 12178889
Gold nanoparticle-ligand conjugates and methods of use
granted -
US 12178861
Stabilized liquid and lyophilized ADAMTS13 formulations
granted -
US 12178887
NIR-conjugated tumor-specific antibodies and uses thereof
granted -
US 12178626
Encapsulated gas or partial vacuum CT contrast material
granted -
US 12180211
Compounds, compositions and methods
granted -
US 12178907
Binary lipid bilayer-containing vesicles comprising embedded cytotoxic agents and methods of making and using the same
granted -
US 12180192
Modulators of THR-Ξ² and methods of use thereof
granted -
US 12180504
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
granted -
US 12181485
Methods of blood screening
granted -
US 12181555
3-dimensional representations of post-contrast enhanced brain lesions
granted -
US 12180300
Targeting moiety-drug grafted immune cell compositions and methods of use
granted -
US 12180503
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
granted -
US 12180463
Lactobacillus reuteri
granted -
US 12180484
Chimeric antigen receptors targeting B-cell maturation antigen
granted -
US 12178909
Manufacturing of bupivacaine multivesicular liposomes
granted -
US 12178921
Method of lyophilizing lipid nanoparticles
granted -
US 12180258
T-cell modulatory multimeric polypeptides and methods of use thereof
granted -
US 12180272
Antigen binding molecule formats
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β best for looking up a specific filing or applicant portfolio slice.